about
sameAs
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohortA comparison of netilmicin and tobramycin therapy in patients with renal impairmentImplementation of a method to visualize noise-induced hearing loss in mass stranded cetaceansProspective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.Reagentless measurement of aminoglycoside antibiotics in blood serum via an electrochemical, ribonucleic acid aptamer-based biosensor.Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.Mycetoma medical therapy.A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides?Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsComparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis PatientsPharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.Cochlear toxicity of butikacin (UK-18,892), a new semisynthetic aminoglycoside antibiotic, in guinea pigs.The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.Aminoglycoside toxicity in neonates: something to worry about?Changes in the inner ear structures in cystic fibrosis patients.Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.Use of ototoxic medications in neonates-the need for follow-up hearing test.Comparative cochlear toxicities of streptomycin, gentamicin, amikacin and netilmicin in guinea-pigs.Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.Auditory effect of kanamycin given to newborn guinea pigs whose mothers received kanamycin during pregnancy.Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.Auditory function after continuous infusion of gentamicin to high-risk newborns.Comment on aminoglycoside evaluation.
P2860
Q27318102-0F051A91-F76E-4F97-97C9-CDE2D5AD817DQ28316869-E5873DA3-83AC-4EDB-996D-96AA56B41CE7Q30363633-E2FF7EC0-02DD-4761-AC10-0030D995AF99Q33727669-1B0D0857-9AE9-44E0-BF7C-7C0CAD80A86AQ34858947-41F1122F-18ED-4E29-8C06-F080B859694AQ34874579-4D2A77C9-73BE-443D-A606-069775E3F29BQ35351362-F1617B0A-D00E-4C78-BE29-3D4D422ED86CQ35689759-CB9A8DA0-03A1-4BBC-A219-90FC34C92921Q35714140-C53740C7-C5A8-47F7-BCC3-1607FBE14C60Q35745224-4B9FD593-40C2-4448-B9F1-33DEE58C9B33Q36075986-E6C13DEC-F219-4231-A0EB-AC235FA45F38Q36459417-0B9915AD-9CF8-4D8F-AF04-983278709FDDQ36483934-F856C5EE-EFA3-4103-A12A-4D437C8B1F08Q37268122-1D367A93-A8F9-4ECF-BC44-855CB76EE342Q38181171-0B57BF20-5EC1-4B57-9471-520742477ABAQ39066887-65110D7A-3332-4F82-92AA-E58E2225C71CQ39598341-4FEEF33E-29A8-4211-8925-B8924D68C942Q41733782-52B80CED-B1B9-4620-8882-5012F783B746Q42067302-07ECB9FE-6DDA-4A7E-83AE-4C0595719105Q44139574-9C522BE1-9433-4AF0-A76F-B76DC09BB795Q45006893-D77406D4-141C-4CA1-9CA8-DF3E71211654Q46493958-F2099F18-2142-413C-B3A9-8AF7634ED032Q50315312-C80B844A-D099-442A-880C-E6166F7649E0Q50555523-7CFF9516-964C-4D3C-9C82-33F60B1321B5Q50594932-8BE3092C-6B3F-47B6-8BF2-9829FD758CE4
P2860
description
1976 nî lūn-bûn
@nan
1976 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Ototoxicity of amikacin
@ast
Ototoxicity of amikacin
@en
Ototoxicity of amikacin
@nl
type
label
Ototoxicity of amikacin
@ast
Ototoxicity of amikacin
@en
Ototoxicity of amikacin
@nl
prefLabel
Ototoxicity of amikacin
@ast
Ototoxicity of amikacin
@en
Ototoxicity of amikacin
@nl
P2093
P2860
P356
P1476
Ototoxicity of amikacin
@en
P2093
P2860
P304
P356
10.1128/AAC.9.6.956
P407
P577
1976-06-01T00:00:00Z